Pharming Analyst Ratings
Pharming Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | 196% | HC Wainwright & Co. | → $37 | Reiterates | → Buy |
| 03/28/2023 | 220% | Oppenheimer | $36 → $40 | Maintains | Outperform |
| 03/27/2023 | 196% | HC Wainwright & Co. | → $37 | Reiterates | → Buy |
| 02/22/2023 | 196% | HC Wainwright & Co. | → $37 | Reiterates | → Buy |
| 02/16/2023 | 196% | HC Wainwright & Co. | → $37 | Reiterates | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/03/2023 | 196% | HC Wainwright公司 | →$37 | 重申 | →購買 |
| 03/28/2023 | 220% | 奧本海默 | $36→$40 | 維護 | 跑贏大盤 |
| 03/27/2023 | 196% | HC Wainwright公司 | →$37 | 重申 | →購買 |
| 02/22/2023 | 196% | HC Wainwright公司 | →$37 | 重申 | →購買 |
| 02/16/2023 | 196% | HC Wainwright公司 | →$37 | 重申 | →購買 |
What is the target price for Pharming (PHAR)?
Pharming(Phar)的目標價是多少？
The latest price target for Pharming (NASDAQ: PHAR) was reported by HC Wainwright & Co. on August 3, 2023. The analyst firm set a price target for $37.00 expecting PHAR to rise to within 12 months (a possible 196.00% upside). 5 analyst firms have reported ratings in the last year.
輝明(納斯達克代碼：PHAR)的最新目標價是由HC Wainwright&Co.於2023年8月3日報道的。這家分析公司將目標價定為37美元，預計法爾將在12個月內上漲(可能上漲196.00%)。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for Pharming (PHAR)?
Pharming(Phar)的最新分析師評級是多少？
The latest analyst rating for Pharming (NASDAQ: PHAR) was provided by HC Wainwright & Co., and Pharming reiterated their buy rating.
分析師對輝明(納斯達克代碼：PHAR)的最新評級是由HC Wainwright&Co.提供的，輝明重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Pharming (PHAR)?
Pharming(Phar)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pharming, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pharming was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Pharming的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Pharming的上一次評級是在2023年8月3日提交的，所以你應該預計下一次評級將在2024年8月3日左右的某個時候公佈。
Is the Analyst Rating Pharming (PHAR) correct?
分析師評級Pharming(Phar)正確嗎？
While ratings are subjective and will change, the latest Pharming (PHAR) rating was a reiterated with a price target of $0.00 to $37.00. The current price Pharming (PHAR) is trading at is $12.50, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Pharming(Phar)評級被重申為目標價在0.00美元至37.00美元之間。Pharming(Pharming)目前的交易價格為12.50美元，在分析師的預測範圍內。